Non-sedating second-generation antihistamine active substances.
Montelukast Sodium (10mg) + Levocetirizine HCl (5mg)
Each 5 ml contains Codeine Phosphate IP 10mg Triprolidine Hydrochloride IP 1.25 mg
Each film coated tablet contains Montelukast sodium IP equivalent to Montelukast 10mg + Fexofenadine HCL IP 120mg, Excepients : QS colour : Ferric Oxide yellow USP NF & Titanium Dioxide IP
Each film coated tablet contains Montelukast sodium IP equivalent to Montelukast 10mg + Levocetrizine Dihydrochloride IP 5mg, Excipients QS, Colour: Ferric oxide (yellow). USP-NF and Titanium Dioxide IP.
Each uncoated tablet contains Levocetrizine Hydrochoride IP 2.5mg + Monotelukast Sodium IP equivalent to Monotelukast 4 mg . Excipeints QS.
Each 5ml contains Montelukast Sodium IP equivalent to Montelukast 4mg + Levocetirizine Dihydrochloride IP 2.5mg flavoured syrup base
Each uncoated tablet contains Levocetrizine Hydrochoride IP 2.5mg + Monotelukast Sodium IP equivalent to Monotelukast 5 mg . Excipeints QS.
Each film coated bilayered tablet contains: Bilastine 20 mg Motelukast Sodium IP Eq. to Montelukast 10 mg Excipients q.s. Colour: Erythrosine Lake (in Montelukast Layer)
